Personal information

Countries

China

Biography

Focus on hematopoietic stem cell transplantation

Activities

Collapse all

Employment (2)

Shanghai Institute of Hematology: Shanghai, CN

2019-05-13 to present
Employment
Source: Self-asserted source
Jieling Jiang

Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine : Shanghai, CN

2019-05-13 to present (hematology)
Employment
Source: Self-asserted source
Jieling Jiang

Works (8)

Fludarabine, busulfan, and melphalan conditioning regimen in allogeneic hematopoietic stem cell transplantation for adult patients with myeloid malignancies: A multicenter retrospective study

eJHaem
2024-08 | Journal article
DOI: 10.1002/jha2.947
Contributors: Jieling Jiang; Xiaofan Li; Dong Wu; Quanyi Lu; Kourong Miao; Houcai Wang; Xiaoping Li; Yingnian Chen; Shiyuan Zhou; Yali Zhou et al.
Source: check_circle
Crossref

Low Incidence of Relapse with a Moderate Conditioning Regimen of Fludarabine, Busulfan, and Melphalan for Patients with Myeloid Malignancies: A Single-Center Analysis of 100 Patients

Transplantation and Cellular Therapy
2023-08 | Journal article
DOI: 10.1016/j.jtct.2023.05.017
Contributors: Jie-ling Jiang; Wen-hui Gao; Li-ning Wang; Ming Wan; Ling Wang; Jiong Hu
Source: check_circle
Crossref

Cladribine-based debulking chemotherapy sequential with reduced intensity regimen and post-transplantation maintenance for refractory myeloid leukemia: a prospective phase II clinical trial.

Bone marrow transplantation
2022-03-29 | Journal article
DOI: 10.1038/s41409-022-01639-0
PMID: 35352037
Contributors: Wang L; Gao W; Wang L; Wan M; Jiang J; Jiong Hu
Source: Self-asserted source
Jieling Jiang

Double alkylators based conditioning reduced the relapse rate after allogeneic peripheral blood stem cell transplantation in adult patients with myeloid malignancies: a single arm phase II study.

Bone marrow transplantation
2022-03-24 | Journal article | Writing - original draft
DOI: 10.1038/s41409-022-01643-4
PMID: 35332301
Contributors: Jiang JL; Chen M; Wang LN; Wan M; Gao WH; Wang L; Jiong Hu; Jieling Jiang
Source: Self-asserted source
Jieling Jiang

Post-transplantation Cyclophosphamide, Tacrolimus and Low-Dose ATG as GVHD Prophylaxis for Allogeneic Peripheral Stem Cell Transplantation for Adult Patients With Lymphoid Malignancies: A Single Arm Phase II Study.

Frontiers in medicine
2021-03-18 | Journal article
DOI: 10.3389/fmed.2021.630160
PMID: 33816524
PMC: PMC8012531
Contributors: Jiang JL; Gao WH; Wang LN; Wan M; Wang L; Hu J
Source: Self-asserted source
Jieling Jiang
grade
Preferred source (of 4)‎

Cord blood infusion-accelerated hematopoietic recovery after combined immunosuppressive therapy with fludarabine and rabbit ATG in severe aplastic anemia.

International journal of hematology
2020-01-03 | Journal article
DOI: 10.1007/s12185-019-02807-7
PMID: 31900878
Contributors: Jiang J; Cai Y; Liping Wan; Yang J; Wang C
Source: Self-asserted source
Jieling Jiang
grade
Preferred source (of 2)‎

Donor Allospecific CD44<sup>high</sup> Central Memory T Cells Have Decreased Ability to Mediate Graft-vs.-Host Disease.

Frontiers in immunology
2019-04-02 | Journal article
DOI: 10.3389/fimmu.2019.00624
PMID: 31001254
PMC: PMC6454869
Contributors: Huang W; wenjian mo; Jiang J; Chao NJ; Chen BJ
Source: Self-asserted source
Jieling Jiang

Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study.

Bone marrow transplantation
2018-11-16 | Journal article
DOI: 10.1038/s41409-018-0382-3
PMID: 30446741
PMC: PMC6760546
Contributors: Yang J; Jiang J; YU CAI; Li S; Liping Wan; Zhu J; Liu H; Shao S; Bai H; Wang C et al.
Source: Self-asserted source
Jieling Jiang
How many people are using ORCID?